Enterprise Value
127.2M
Cash
11.91M
Avg Qtr Burn
-1.452M
Short % of Float
3.93%
Insider Ownership
54.21%
Institutional Own.
5.25%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GP2 Details Breast cancer | Phase 3 Interim Update | |
GLSI-100 Details HER2 Breast cancer | Phase 2b Update |